197 related articles for article (PubMed ID: 37138437)
1. An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches.
Vig H; Ravinandan AP; Vishwas HN; Tyagi S; Rathore S; Wal A; Wal P
Curr Diabetes Rev; 2024; 20(1):e020523216416. PubMed ID: 37138437
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
Khan S; Ahmad SS; Kamal MA
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
Borghetti G; von Lewinski D; Eaton DM; Sourij H; Houser SR; Wallner M
Front Physiol; 2018; 9():1514. PubMed ID: 30425649
[TBL] [Abstract][Full Text] [Related]
6. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Huynh K; Bernardo BC; McMullen JR; Ritchie RH
Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
[TBL] [Abstract][Full Text] [Related]
7. Heart Failure in Type 2 Diabetes Mellitus.
Kenny HC; Abel ED
Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M; Li Y; Li S; Lv J
Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
[TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
[TBL] [Abstract][Full Text] [Related]
10. Medicinal chemistry of drugs used in diabetic cardiomyopathy.
Adeghate E; Kalasz H; Veress G; Teke K
Curr Med Chem; 2010; 17(6):517-51. PubMed ID: 20015035
[TBL] [Abstract][Full Text] [Related]
11. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
Seferović PM; Paulus WJ
Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
Rajesh M; Bátkai S; Kechrid M; Mukhopadhyay P; Lee WS; Horváth B; Holovac E; Cinar R; Liaudet L; Mackie K; Haskó G; Pacher P
Diabetes; 2012 Mar; 61(3):716-27. PubMed ID: 22315315
[TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs.
Zhou Y; Suo W; Zhang X; Liang J; Zhao W; Wang Y; Li H; Ni Q
Biomed Pharmacother; 2023 Dec; 168():115669. PubMed ID: 37820568
[TBL] [Abstract][Full Text] [Related]
15. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
Mizamtsidi M; Paschou SA; Grapsa J; Vryonidou A
Eur J Clin Invest; 2016 Nov; 46(11):947-953. PubMed ID: 27600276
[TBL] [Abstract][Full Text] [Related]
16. Are targeted therapies for diabetic cardiomyopathy on the horizon?
Tate M; Grieve DJ; Ritchie RH
Clin Sci (Lond); 2017 May; 131(10):897-915. PubMed ID: 28473471
[TBL] [Abstract][Full Text] [Related]
17. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus.
Graczyk P; Dach A; Dyrka K; Pawlik A
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732253
[TBL] [Abstract][Full Text] [Related]
19. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Joubert M; Jagu B; Montaigne D; Marechal X; Tesse A; Ayer A; Dollet L; Le May C; Toumaniantz G; Manrique A; Charpentier F; Staels B; Magré J; Cariou B; Prieur X
Diabetes; 2017 Apr; 66(4):1030-1040. PubMed ID: 28052965
[TBL] [Abstract][Full Text] [Related]
20. The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats.
Abdel-Mageid AD; Abou-Salem MES; Salaam NMHA; El-Garhy HAS
Phytomedicine; 2018 Apr; 43():126-134. PubMed ID: 29747745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
